{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:04:36Z","timestamp":1756425876382,"version":"3.44.0"},"reference-count":10,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>The link between cancer and venous thromboembolism is well known, with an annual incidence rate of venous thromboembolism between 0.5% and 20% depending on the primary site and background risk factors. Current guidelines suggest treatment with low-molecular-weight heparin over oral vitamin K antagonists. However, data regarding the management of recurrent venous thromboembolism when the patient is under treatment with anticoagulants are sparse. In this article we present a patient with multiple thromboembolic events in unusual sites despite anticoagulant treatment and we discuss the management options.<\/jats:p>","DOI":"10.1136\/bcr-2013-200502","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T08:55:41Z","timestamp":1379408141000},"page":"bcr2013200502","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["A 52-year-old-male patient with metastatic non-small-cell lung cancer and recurrent venous thromboembolism in unusual sites despite anticoagulation"],"prefix":"10.1136","volume":"2013","clinical-trial-number":[{"clinical-trial-number":"nct01852578","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01130025","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Alexios","family":"Matikas","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Vardakis","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Souglakos","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios","family":"Georgoulias","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,9,17]]},"reference":[{"key":"2025082804264901000_2013.sep17_1.bcr2013200502.1","doi-asserted-by":"crossref","first-page":"e1001275","DOI":"10.1371\/journal.pmed.1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"2013","author":"Horsted","year":"2012","journal-title":"PLoS Med"},{"key":"2025082804264901000_2013.sep17_1.bcr2013200502.2","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"2013","author":"Lyman","year":"2013","journal-title":"J Clin Oncol"},{"key":"2025082804264901000_2013.sep17_1.bcr2013200502.3","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1158\/1078-0432.CCR-09-0371","article-title":"Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy","volume":"2013","author":"Zwicker","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2025082804264901000_2013.sep17_1.bcr2013200502.4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001721-199703000-00001","article-title":"Cancer procoagulant: a factor\u00d7activator, tumor marker and growth factor from malignant tissue","volume":"2013","author":"Gordon","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2025082804264901000_2013.sep17_1.bcr2013200502.5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jth.12075","article-title":"Coagulation and cancer: biological and clinical aspects","volume":"2013","author":"Falanga","year":"2013","journal-title":"J Thromb Haemost"},{"key":"2025082804264901000_2013.sep17_1.bcr2013200502.6","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1200\/JCO.2012.42.4358","article-title":"Risk of venous thromboembolism in patients with cancer treated with cisplatin: a systematic review and meta-analysis","volume":"2013","author":"Seng","year":"2012","journal-title":"J Clin Oncol"},{"key":"2025082804264901000_2013.sep17_1.bcr2013200502.7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"2013","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"2025082804264901000_2013.sep17_1.bcr2013200502.8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.111.051920","article-title":"Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism","volume":"2013","author":"Louzada","year":"2012","journal-title":"Circulation"},{"key":"2025082804264901000_2013.sep17_1.bcr2013200502.9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2009.03326.x","article-title":"Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients","volume":"2013","author":"Carrier","year":"2009","journal-title":"J Thromb Haemost"},{"key":"2025082804264901000_2013.sep17_1.bcr2013200502.10","doi-asserted-by":"crossref","first-page":"141S","DOI":"10.1378\/chest.08-0689","article-title":"Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"2013","author":"Hirsh","year":"2008","journal-title":"Chest"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-200502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T11:27:08Z","timestamp":1756380428000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-200502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,17]]},"references-count":10,"alternative-id":["10.1136\/bcr-2013-200502"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-200502","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2013,9,17]]}}}